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Abstract
This chapter reviews common cutaneous infections, infestations, and neoplasms of the 
scalp. Infections of the scalp are subdivided into three major groups. The most seen are: 
(1) Bacterial: Folliculitis, folliculitis decalvans, tufted hair folliculitis and acne keloidalis 
nuchae. (2) Fungal: Tinea capitis, favus and kerion celsi. (3) Protozoal: Syphilitic alope-
cia. Pediculosis capitis is the most common worldwide infestation of the scalp. The neo-
plasms of the scalp are large group of different diseases due to arising different origin. In 
the following section, trichilemmal cyst, proliferating trichilemmal cyst, nevus sebaceous 
and cylindroma are discussed in detail.
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1. Introduction
Scalp diseases are one of the most seen reasons for admission to dermatology clinics. There is 
a wide spectrum of different aetiologies for scalp lesions. This chapter will review cutaneous 
infections, infestations and neoplasms of the scalp. Examples of bacterial infections include 
folliculitis, folliculitis decalvans, tufted hair folliculitis and acne keloidalis nuchae. There will 
be some detailed information about fungal infections, such as tinea capitis, favus and kerion 
celsi. The neoplasms of the scalp represent a varied group of dermatoses. This review focuses 
on trichilemmal cyst, proliferating trichilemmal cyst, nevus sebaceous and cylindroma.
2. Bacterial infections of scalp
There are several types of infections of the scalp including chronic scalp folliculitis [SF], fol-
liculitis decalvans [FD], tufted folliculitis [TF], acne nuchae keloidalis [ANK] and dissecting 
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cellulitis [DCS]. These infections have similar features like chronic scarring folliculocentric 
pustules localised to the scalp. Many of these conditions show the presence of Staphylococcus 
aureus [SA] and response to antibiotic therapy [1].
2.1. Scalp folliculitis
Folliculitis is a pyoderma that begins within the hair follicle. It is classified according to the 
microbial aetiology, including bacteria, viruses and fungi, as well as many other non-infec-
tious ones. The most seen folliculitis of scalp are Staphylococcus aureus [S. aureus] folliculitis, 
Herpes simplex virus folliculitis and dermatophytic folliculitis [Tinea capitis]. Some of the 
predisposing factors are hyperhidrosis, maceration, friction, overweight, medications such as 
corticosteroids and halogenated compounds, as well as occlusive hair care products and topi-
cal hydrocarbons, such as oils and tars. In addition, immunodeficiencies such as HIV/AIDS 
and diabetes mellitus are also predisposed to folliculitis [2].
S. aureus is the most common cause of folliculitis. The major cause is either contagion or auto-
inoculation from a carrier focus, usually nasal or perianal region. The typical lesion of follicu-
litis is a small inflamed, dome-shaped papule or pustule which can be drained spontaneously. 
Both pruritus and pain can be seen. Systemic symptoms, such as fever or lymphadenopa-
thy, may occur when the involvement is widespread. Biopsy is rarely needed to distinguish 
between fungal or viral folliculitis. Biopsy shows neutrophils in the dermis and follicular 
wall damage. Many of the patients may carry S. aureus, so nasal and perineal cultures should 
be taken. Other forms of folliculitis can be identical in appearance, so this possibility should 
always be taken into consideration. Treatment options include topical antibiotic or disinfec-
tant solutions such as mupirocin cream, triclosan [2%] or chlorhexidine [1%] and antistaphy-
lococcal systemic antibiotics [1, 2].
2.2. Folliculitis decalvans
Folliculitis decalvans [FD] is a rare type of cicatricial alopecia and was first described by 
Quinquaud in 1881 [3]. It is an inflammatory disease characterised by follicular pustules and 
haemorrhagic crusting, leading to scarring hair loss. Although in most patient FD started 
in the vertex, other sites such as the occipital or midscalp area may also be affected. At the 
periphery of lesion, follicular pustules continue to form. Tufting of hairs may be seen [4]. 
Clinically, the majority of the patients were generally healthy, without any systemic symp-
toms or any signs of immunosuppression. Although the exact cause remains unknown, 
S. aureus is usually cultured from these pustules [5]. The disease shows a chronic and relaps-
ing course. Histologically, early lesions show dense perifollicular inflammatory infiltrates 
consisting mostly of neutrophils. In later stages, follicular rupture, lymphocytes, histiocytes 
and plasma cells are seen, as well as perifollicular and interstitial dermal fibrosis [6, 7]. 
Differential diagnosis of FD consists of follicular degeneration syndrome or central centrifu-
gal scarring alopecia.
As FD is usually associated with infection of S. aureus [5, 6], systemic antibiotics are the mainstay 
of disease [e.g., cephalexin, minocycline, tetracycline, clindamycin, rifampicin, ciprofloxacin]. 
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Because of its high lipid solubility, and it is said to be the best antistaphylococcal antibiotic, 
rifampicin has been successfully used in combination with various other antibiotics [5, 7]. 
Rifampicin is not recommended for lone use. Rifampicin 300 mg b.i.d and clindamycin 300 mg 
b.i.d is the preferred regimen. Shampooing with antibacterial wash products and topical cor-
ticosteroids may also be useful. Varying results have been reported after treatment with pred-
nisolone, isotretinoin, human immunoglobulin and more recently biologics [e.g., infliximab and 
adalimumab] [8, 9], neodymium: yttrium aluminium-garnet [Nd:YAG] laser [10] and photody-
namic therapy [PDT] [11]. There is very limited evidence that FD can be treated with dapsone, 
minoxidil or radiation therapy [12].
2.3. Tufted hair folliculitis
Tufted hair folliculitis [THF] was first described by Smith and Sanderson in 1978 [7]. It is 
characterised by scarring bacterial folliculitis of the scalp associated with multiple bundles of 
hair emerging from a single dilated follicular orifice in a ‘doll’s hair’ pattern. Infection with 
S. aureus is thought to be initial causative factor [13]. Tufting of hair is caused by clustering 
of adjacent follicular unit due to a fibrosing process and to retention of telogen hairs within a 
dilated follicular orifice [14]. The patients were 20–60 years old, the peak incidence occurring 
in 30 years [4]. It affects male more frequently than female.
Clinically, it presents erythematous, infiltrated plaque of cicatricial alopecia and enlarged 
follicular openings with tufts containing 20–30 apparently normal hair shafts (Figure 1). The 
lesions are usually found in the occipital and parietal areas [8]. Frequently reported subjective 
symptoms are pruritus, pain and scales adherent to the scalp and hair. Regional lymph node 
enlargement [occipital, pre- or retroauricular] may also be noticed [9]. S. aureus is most often 
cultured from the lesions [10]. Underlying differences in follicular anatomy or host response 
may be responsible for the lesion [15]. Histopathological studies reveal scarring with perifol-
licular inflammation of plasma cells, lymphocytes and neutrophils around the upper portions 
of the follicles sparing at the hair root level. Multiple hairs are seen emerging from a single 
follicular opening (Figure 2) [13].
Figure 1. Cicatricial alopecia with tufted folliculitis.
Infections, Infestations and Neoplasms of the Scalp
http://dx.doi.org/10.5772/67278
201
THF may be seen with dissecting cellulitis of the scalp, folliculitis decalvans, acne keloidalis, 
Melkersson-Rosenthal syndrome and hidradenitis suppurativa [16]. In some case reports it 
has been described that tufted folliculitis in association with medication use, specifically with 
cyclosporine and lapatinib [17, 18]. Differential diagnosis consists of folliculitis decalvans, 
folliculitis keloidalis nuchae, kerion celsi, dissecting cellulitis of scalp, trichostasis spinulosa, 
follicular lichen planus and relapsing staphylococcal folliculitis [19].
The course of THF is chronic and the patient may experience intermittent flares and remis-
sions. Treatment of this relapsing condition is notoriously difficult. As S. aureus is the initial 
causative agent, systemic antibiotics including ciprofloxacin, erythromycin, flucloxacillin 
and amoxicillin/clavulanic acid are regarded the standard therapy. Rifampicin and nadi-
floxacin have been proven as more effective than other therapeutic modality to control the 
pustular phase of the disease, of the best antibiotics active against S. aureus, as well as to 
prevent possible recurrences [4, 20]. Rifampicin can be used with a dose of 450 mg twice per 
day for 4 weeks or 600 mg daily for 10 weeks [20, 21]. Recently, a case of tufted hair folliculi-
tis being treated with trastuzumab, a selective HER2 inhibitor, has been reported [22]. Good 
results with excision of the areas of scarring have also been described [13, 15].
2.4. Acne keloidalis nuchae
Acne keloidalis nuchae [AKN] is a chronic scarring folliculitis characterised by fibrotic, keloid-
like papules and plaques on the occipital scalp and posterior neck. The term acne keloidalis 
was given to this condition in 1872 by Bazin [23].
Early AKN lesions are seen as mildly pruritic papules and pustules arranged in irregu-
larly linear groups just below the hairline. With continued inflammation or infection the 
Figure 2. Dermoscopic image of the scalp with tufted folliculitis characterised by multiple hairs emerging from one 
single dilated follicular orifice.
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Figure 3. Acne keloidalis nuchae. Papules are seen below the hairline.
Figure 4. Acne keloidalis nuchae. Papules and hypertrophic scars are noticed on the occipital region.
papules tend to coalesce and form hypertrophic scars or keloids that may be painful and 
disfiguring (Figures 3 and 4). In advanced cases, abscesses and sinus tracts with puru-
lent discharge may develop [24, 25]. Actually AKN is not a form of acne vulgaris and 
unlike true acne vulgaris, comedones are not a feature of AKN. It is very common in 
individuals of African descent. Its prevalence ranges from 1 to 16% and the male to female 
ratio is at least 20:1. The probable onset age of AKN is 15–25 years and reduces after 
55 years of age [26].
The exact aetiology of AKN is unclear but it is associated with several factors including 
androgen excess, chronic mechanical trauma such as close haircuts and chronic rubbing of 
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the area by clothing stimulating an inflammatory reaction, secondary bacterial infection, 
mast cell density and medications such as antiepileptic drugs or cyclosporine [24, 26–28].
Histological studies show evidence of follicular and perifollicular infiltrate at the upper one-
third of the hair follicle in early lesions, whereas more advanced lesions reveal disrupted 
hair follicles, a foreign-body reaction with granulomatous inflammation and fibrotic dermis 
[25, 29]. Differential diagnosis of AKN consists of the other chronic scarring folliculocentric 
pustules localised to the scalp.
First step in treatment is patient education. It should be advised that the patient should avoid 
from mechanical irritation from clothing for prevention. Prognosis becomes good if the treat-
ment begins at early stage. However, once major scarring develops, therapy is more difficult 
and morbidity is increased. If pathogenic microorganism with culture are identified, appro-
priate antibiotics should be prescribed. Conventional treatment modalities usually involve 
use of topical, intralesional or systemic steroids in combination with retinoids and/or oral 
antibiotics such as doxycycline or minocycline to decrease inflammation. Oral isotretinoin of 
20 mg daily may be used alone or in combination with topical fusidic acid and oral cefadroxil 
[500 mg twice daily for 2 weeks] to treat the patient [30]. Other treatment options are cryo-
therapy and targeted ultraviolet B [290–320 nm] phototherapy. Combination of cryotherapy 
and intralesional steroid may help to reduce the size and firmness of papules and nodules 
[31]. Radiation therapy and intralesional 5-fluorouracil are alternative treatment strategies 
for refractory cases [32]. Recently, laser treatment such as CO
2
 laser, 1064-nm Nd:YAG laser, 
59-nm pulse dye laser [PDL] and 810-nm diode laser have been used which allow for 82–95% 
improvement in one to five sessions [33]. Patients who present with big fibrotic nodules would 
benefit most from surgical excision. Excision with primary closure may be used for excellent 
cosmetic results for the management of extensive cases of AKN [23, 28, 34].
3. Fungal infections of scalp
3.1. Tinea capitis
Tinea capitis (TC) is a disease caused by dermatophytes of the skin of the scalp with a pro-
pensity for attacking hair shafts and follicles. It occurs predominantly in pre-pubertal children 
aged between 3 and 7 years. It is reported more in boys than in girls within pre-pubertal age. 
Tinea capitis is the most seen pediatric dermatophyte infection worldwide [35]. All species 
of Trichophyton and Microsporum can cause TC. Microsporum canis is the cause of the most 
seen dermatophyte worldwide, whereas in the United States Tricophyton tonsurans is the most 
common organism. Transmission occurs by direct head-to-head contact through fomites, 
from animals to humans, and, least commonly, acquired from soil. Asymptomatic carriers of 
Tricophyton tonsurans are common, making it difficult to treat [36].
From the site of inoculation, the fungal hyphae grow centrifugally in the stratum cor-
neum. According to the patterns of contamination, tinea of the scalp is classified into two 
types: ectothrix and endothrix. In an ectothrix infection, the fungi continue downward 
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growth into the follicle and they invade the keratin part of the hairs. Ectothrix invasion 
is usually associated with Trichophyton verrucosum, Trichophyton mentagrophytes and all 
Microsporum species. The endothrix hair invasion caused by Trichophyton tonsurans and 
Trichophyton violaceum is characterised by the development of the fungi within the hair 
shaft only. While the ectothrix-infected hairs can be of fluoresce bright green or yellow 
green caused by the destruction of the cuticle of the hair, the endothrix infection do not 
fluoresce, because the cuticle of the hair remains intact in endothrix infection. The hair is 
very fragile and breaks the surface of the scalp. Therefore, leaves the infected dark stubs 
visible in the follicular orifices. Thus, endothrix infection is often described as a ‘black 
dot’ appearance [37].
Among predisposing factors for dermatophyte infections are humid environment, atopic 
diathesis, such as cell-mediated immune deficiency, systemic immunocompromised states, 
prolonged immunosuppression with the use of topical glucocorticoids and broad-spectrum 
antibiotic use [38].
Typical clinical features are small areas of fine scale with minimal hair loss. ‘Moth-eaten’ 
alopecia is seen. When Tricophyton tonsurans is responsible, black dots are seen. Erythema is 
also a clue for Microsporum canis. Shedding of fungal spores may continue several months 
despite active treatment; therefore, children with tinea capitis may attend school. Also, short 
haircuts and wearing a cap during treatment are not necessary. Clinical manifestations of TC 
may resemble pityriasis amiantacea, seborrheic dermatitis, bacterial folliculitis, pediculosis 
capitis, trichotillomania, alopecia areata or pustular psoriasis, which are often treated incor-
rectly [39].
Definitive diagnosis of TC is made through 10–20% potassium hydroxide [KOH] examination 
and culture from lesions. The turn-around time for culture may take several weeks. Wood 
light examination is also helpful to demonstrate fungal fluoresce. Infected hair produces 
bright green or yellow green fluorescence. It should be kept in mind that endothrix organisms 
do not fluoresce. Trichoscopy is an additional tool for the diagnosis of tinea capitis. Comma 
shaped hairs, corkscrew hairs and zigzag shaped hairs are the diagnostic trichoscopic features 
of tinea capitis [40, 41]. Skin biopsy can be done for differential diagnosis. Fungal hyphae in 
the stratum corneum can be demonstrated histopathologically.
As the dermatophyte penetrate the hair follicle, oral antifungals is required for the treatment 
of TC. Basically, three different groups of systemic antifungals are used to eliminate TC: 
Griseofulvin, azoles [itraconazole, fluconazole, ketoconazole] and allylamines [terbinafine]. 
Of these agents, itraconazole and terbinafine are most commonly used. Griseofulvin [10–25 
mg/kg/day for 6–8 weeks] is the most frequently used antifungal agent, but recently it has also 
been reported that newer agents such as terbinafine [10–20 kg: 62.5 mg/day; 20–40 kg: 125 mg/
day; >40 kg: 250 mg/day for 2–4 weeks], itraconazole [5 mg/kg/day for 2–6 weeks] and fluco-
nazole [first dose 6–12 mg/kg, then 3–6 mg/kg/day for 2–4 weeks] to be effective. Selenium 
sulphide, zinc pyrithione, povidone iodine or ketoconazole shampoos have been shown to 
help to decrease the shedding of fungal spores. Common recommendations are to use these 
shampoos two to four times weekly for 2–4 weeks [42, 43].
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3.2. Favus
Favus or tinea favosa is the most severe form of tinea capitis. It is caused by Tricophyton 
schoenleinii. The disease frequently occurs in children and is seen rarely in adults. If untreated, 
the disease persists forever. Favus is seen almost exclusively in Africa, the Mediterranean and 
the Middle East and, rarely, in North America and South America [44].
The most common clinical manifestations on the scalp are yellowish cup-shaped crusts 
termed scutula, which surround the infected hair follicles. The scutula have an unpleasant 
mousy odour. Besides the scalp, it may involve glabrous skin, hairy regions and nails. If not 
treated properly, the lesion advances peripherally and it can leave scarring alopecia [45, 46].
The diagnosis is confirmed by direct mycological examination and culture. A greyish-green 
fluorescence may be observed with Wood’s lamp examination. Optical microscopy with KOH 
preparation shows invasion by the fungus, hyphae parallely arranged to the axis, air spaces 
and a few spores.
In presence of scaly patches without alopecia, favus is misdiagnosed as seborrheic dermatitis, 
psoriasis, tinea amiantacea or lichen planus [47, 48].
The treatment of tinea favosa lies on the combination of an oral and topical antifungal agents. 
The local treatment consists in cutting of hair around the alopecia patches and applying once 
or twice a day of antifungal imidazol [shampoo, foam gel, lotion and spray]. Griseofulvin 
terbinafine and itraconazole could be used in systemic therapy [44, 45].
3.3. Kerion
Kerion celsi [KC] [so-called deep tinea capitis] is an uncommon inflammatory presentation 
of tinea capitis [TC], which appears as a boggy, large inflammatory painful mass studded 
with broken hairs, pustules and, often, purulent drainage from its surface (Figure 5). Hair 
loss is frequently seen in KC. It is usually solitary but multiple lesions may be found. Reactive 
lymphadenopathy, especially cervical or suboccipital, is a very common associated feature. 
KC often occurs in children but it has been described in elderly patients [49–51]. The higher 
Figure 5. Boggy, large inflammatory painful plaque lesion is seen.
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prevalence in females may be related to fact that they generally have longer hair [52]. KC is 
a markedly inflammatory type of TC secondary to a vigorous host immune response. It is 
generally caused by zoophilic dermatophytes [Microsporum canis and Trichophyton mentagro-
phytes], but also by anthropophilic [Trichophyton rubrum] and rarely by geophilic [Microsporum 
gypseum] species. KC is thought to be the result of a hypersensitivity reaction to dermato-
phytes [49].
The main source of the fungi responsible for KC is from humans or animals, though dermato-
phytes may spread via fomites [combs, hairbrushes, hats and contaminated wearing materials]. 
Although the gold standard diagnostic method is fungal culture, conventional sampling of 
a kerion can be difficult. Negative results are not uncommon in these cases. The diagnosis of 
kerion is usually made clinically. A moistened standard bacteriological swab taken from the 
pustular areas and inoculated onto the culture plate may yield a positive result [53].
Id reactions [so-called dermatophytid] are noted in patients with KC. This is an often pru-
ritic dermatitis based on sensitisation to fungal antigens, reported in 4–5% of fungal infection. 
Although it may mimic an allergic reaction, it should not lead to discontinuation of antifungal 
treatment [54]. Acute vesicular dermatitis of the hands and feet is the most common type of 
id reaction. Other less common types of id reactions include annular erythema and erythema 
nodosum. These patients have a strong delayed-type hypersensitivity [DTH] reaction to intra-
dermal trichophytin. EN is thought to be due either the deposition of immune complexes in cap-
illaries and venules of the dermal and adipose plexus, or to a DTH reaction to an antigen [55, 56].
The principal differential diagnoses consist of impetigo and bacterial or sterile folliculitis or 
abscesses. KC is usually misdiagnosed as bacterial abscesses. However, bacterial infections 
do not cause alopecia, and hairs plucked from a kerion are painless. Diagnostic errors causes 
patients to undergo unnecessary surgery or antibiotic treatment. However, there is little evi-
dence to support the use of antibiotics for severe KC [49]. Kerion celsi requires treatment with 
systemic antifungals to penetrate the affected hair shafts. Early short course of glucocortico-
steroids with a dose of 1 mg/kg/day were often used in severe KC to reduce inflammation. 
Oral steroid is tapered to withdraw in 10 days. Manual pressure to remove pus from sinuses 
was an adjuvant therapy to systemic oral antifungal agents for severe KC.
4. Protozoal infection of scalp
4.1. Syphilitic alopecia
Syphilis is a sexually transmitted disease caused by Treponema pallidum. Syphilitic alopecia 
[SA] is an uncommon feature of secondary syphilis with an incidence of 2.9–11.2% [57]. The 
physical examination findings include numerous non-scarring, non-inflammatory, irregular 
in size without defined borders, ‘moth-eaten’ patches of alopecia of the scalp [58]. The eye-
brows and beard may also be involved. SA can be seen with other mucocutaneous symp-
toms of secondary syphilis. Hair loss usually occurs late in the secondary syphilis, about 8–12 
weeks after the first signs of secondary syphilis [59].
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According to the patterns of McCarthy made in 1940, secondary SA is classified into two 
types: symptomatic SA and essential SA. The other cutaneous manifestations of syphilis is 
not seen in essential SA. Essential SA, characterised by alopecia without any other visible 
syphilitic lesions on the scalp, may appear as one of three different clinical patterns: ‘moth-
eaten’ alopecia, diffuse alopecia and mixed pattern of alopecia [58, 60]. The ‘moth-eaten’ pat-
tern alopecia [alopecia syphilitica] is considered the most common and characteristic form of 
secondary syphilis [61, 62].
The diagnosis of SA is confirmed by both patient’s sexual history and positive serological 
tests for RPR and TPPA. The histopathology findings of SA usually include a normal epider-
mis with areas of follicular hyperkeratosis. While the number of anagen follicles are reduced 
markedly, the number of catagen and telogen follicles increase. A perivascular and perifol-
licular [especially in the peribulbar region] lymphocytic dermal infiltration with scattered 
plasma cells is observed in some cases [63].
The differential diagnosis of ‘moth-eaten’ alopecia includes alopecia areata, trichotilloma-
nia and tinea capitis except from syphilis [64]. Under trichoscopy black dots, focal atrichia, 
hypopigmentation of hair shaft and yellow dots are observed in the hair loss region. Alopecia 
areata, tinea capitis and trichotillomania differ from SA with absence of exclamation hair, 
coma hair, flame hairs or v-sign, respectively [57].
The antisyphilitic treatment with a weekly dose of 2.4 million units of benzathine penicillin for 
3 weeks or procaine penicillin 600,000 units i.m. daily for 10 days leads to complete resolution of 
alopecia. Hair growth is observed about 6–12 weeks after the start of the treatment [57, 65, 66].
5. Infestations of scalp
5.1. Pediculosis capitis
Pediculosis capitis [PC] [head lice] is a major worldwide infestation caused by Pediculus huma-
nus capitis seen in school-aged children of 3–12 years of age. The prevalence of PC is usually 
higher in girls and women and varies greatly from country to country. It is 0.7–59% in Turkey, 
0.48–22.4% in Europe, 37.4% in England, 13% in Australia, up to 58.9% in Africa and 3.6–61.4% 
in the Americas [67]. There are estimates that 6–12 million children in the United States are 
infected with PC annually [68]. The prevalence in 5318 elementary school children, aged 8–16 
years in Mersin, Turkey, was 6.8% [69]. In another study of 1569 school children, aged 7–14 
years, the prevalence of head lice was 16.6% [70]. It tends to be more prevalent in children 
because they have a high incidence of head-to-head contact with other children. Girls were at 
a greater risk for head lice because of their tendency to have longer hair than boys and social 
behaviour [close contact].
The lice are spread by direct head-to-head contact as well as by the sharing of clothing, head-
gear, hats, combs, hairbrushes, hair barrettes and pillows. PC affects all socioeconomic classes. 
Although direct contact with an infested individual can cause PC, personal and environmen-
tal hygiene are not risk factors for PC [71].
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The head louse [plural-lice] is an ectoparasite whose only host is humans for survival. There 
are three stages that comprise the life cycle of the louse: egg, nymp and adult. Adult female 
louse lays their eggs [nits] on hair shafts. The nits are usually laid close to scalp for warmth, 
because they must stay warm in order to hatch. These nits cannot be moved along the hair 
shaft in contrast to pseudonits. Only in warmer climates, nits can be found 15 cm or more 
from the scalp, especially favour the nape of the neck. They are of size 0.8 mm × 0.3 mm, oval 
and usually yellow to white and are located 6 mm from scalp. Nits take about 1 week to hatch 
[range 6–9 days]. The nit hatches and release a single nymph. Nymph becomes an adult after 
three molts, about 7–10 days after hatching. Each instar molts every 3–4 days, and after the 
third molt, it becomes adult louse (Figure 6). The first and second instar or nymph forms are 
relatively immobile. Mobile forms are the third instar forms and adults form. The mature 
adult louse is approximately the size of a sesame seed [2–3 mm] and is tan to greyish-white 
[68, 72, 73]. Female lice are larger than males and must take blood before copulation. After 
copulation she lays between 5 and 10 eggs a day. The adult males usually do not survive after 
copulation. The adult louse lives only up to 36 hours away from its host. Head lice can travel 
up to 23 cm/min by crawling. The head lice do not attach firmly to smooth surfaces [e.g., glass, 
metal, plastic, synthetic leathers] [72, 74].
The head louse takes a blood meal [hematophagia] usually 4–5 times per day. Chronic and 
heavy lice infestation can rarely lead to anaemia, especially in females. Pruritus is the most 
common complaint and is believed to be the result of a hypersensitivity reaction to the saliva 
of lice. On examination, nits are seen that firmly attached to hair shaft within 6 mm from the 
scalp skin especially in the occipital pit [louse pit] and retro-auricular areas. Scratches on 
the skin may lead to secondary bacterial infection and impetiginisation. Serous purulent dis-
charge may result in the formation of a plica [plica polonica or plica neuropathica]. There are 
innumerable nits and live lice in patients with plica polonica. Cervical lymphadenopathy and 
conjunctivitis may also be seen. Lice infestation can cause allergic reactions within the nasal 
cavity manifested by nasal obstruction and rhinorrhea [72, 74, 75].
Figure 6. Schematic representation of life cycle of head louse.
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The diagnosis of head lice infestation is made through finding viable eggs [nits], nymphs and 
live adult lice. For the diagnosis, the use of a louse comb is more efficient than direct visual 
examination of the scalp [76]. Examining suggestive particles under the microscope may be 
helpful to confirm the diagnosis. Non-contact dermoscopy is also a useful instrument for dif-
ferentiate nymph-containing eggs from empty cases or pseudonits [72]. Histology is rarely 
required for diagnosis. Examination of a louse bite reveals intradermal haemorrhage and a 
deep, wedge-shaped infiltrate with many eosinophils and lymphocytes.
Differential diagnosis of head lice includes seborrheic scales, hair casts [inner root sheath rem-
nants], pityriasis amiantacea, white piedra, black piedra, impetigo, pili torti and monilethrix. It 
should kept in mind that, in contrast to nits, hair casts are freely movable along hair shaft [72].
Basically, therapeutic wet combing, topical application of a pediculicide and oral treat-
ment [Trimethoprim-sulfamethoxazole and ivermectin] are used to eliminate head lice. Wet 
combing is a mechanical removal of the lice. The patients must comb their wet hair with 
a fine-toothed comb every 3–4 days for a total of 2 weeks. If all young lice are combed out 
a few days after hatching, the infestation can be eradicated completely. Pediculicides are the 
most effective treatment for head lice. They can be divided into three types. Pediculisides with 
neurotoxic mode of action are permetrin [Nix®], pyrethrin [Rid®], malathion [Ovide®], car-
baryl, lindan [Kwell®] and spinosad [Natroba®]. Dimeticones [Nyda®, Hedrin®], isopropyl 
myristate [Resultz®] and 1,2-octanediol are the pediculicides with physical mode of action. 
The other group of pediculicides is plant-based pediculicides. All topical preparations are 
used for two or three applications, 1 week apart [68, 71].
Because permetrin and pyretrin are non-ovicidal, they should be reapplied on days 7 and 
13–15. Permethrin 1% is a synthetic pyrethroid and is approved for use in children aged 
2 months or older. It shows neurotoxic effect by inhibiting the sodium ion flux through nerve 
cell membrane channels [68]. It should be applied on damp unconditioned hair for 10 min and 
then rinsed off. Pruritus, erythema and edema are its usual side effects [77]. Pyretrin is used 
for children aged 2 years and older. Malathion is a cholinesterase inhibitor. It is approved for 
use in individuals aged 6 years or older. Both malathion and lindan are ovicidal. Spinosad is 
ovicidal, killing both eggs and lice and also kills permethrin-resistant populations of lice. It 
is approved in patients aged 4 years and older [78]. Oral ivermectin is administered a single 
dose of 200 μg/kg and repeated in 10 days. It is restricted to children older than 5 years and 
weighing at least 15 kg [71].
Resistance of lice to the pediculocides is an important problem. Spinosad, benzyl alcohol 
5% or malathion 0.5% may also be used, in case of resistance, for those older than 6 and 
24 months, respectively. Another treatment option is manual removal of nits [especially the 
ones within 1 cm of the scalp]. It is recommended after treatment with any product. Besides 
these treatments, occlusive agents such as petroleum jelly, vinegar, isopropyl alcohol, olive 
oil, mayonnaise and melted butter can been used once per week for 3 weeks to suffocate the 
lice [68, 78].
Patients with head lice should have laundered potential fomites [e.g., towels, pillowcases, 
sheets, hats, toys] with hot water [at least 130°F/55°C] and then dried in a dryer using the 
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hottest cycle. For items that are not machine washable, dry-cleaning may be an effective alter-
native or storing for 2 weeks in a plastic bag. Children should also be educated not to share 
combs, brushes, hair accessories and towels and to avoid head-to-head contact [72, 73, 78].
6. Neoplasms of scalp
The neoplasms of the scalp consist of large group of different diseases due to arising different 
origin. They can be divided into two groups: benign and malignant. They can be categorised 
as shown in Table 1. The common benign swellings of the scalp are the epidermoid cysts, 
trichilemmal cysts, lipomas, dermoid cyst, pilomatrixoma, steatocystoma multiplex and cyl-
indroma. In this section, neoplasms especially which is most seen and is arising from scalp 
are discussed in detail.
6.1. Trichilemmal cyst
Trichilemmal cyst [TC] also known as ‘pilar cyst’ is an adnexal tumour that arises from outer 
root sheath of the hair follicle. It is almost always benign but may be locally aggressive. 
Malignant transformation is very rare but may lead to distant metastases [77, 79].
Benign neoplasms Malignant neoplasms
Epidermoid cysts Basal cell carcinoma
Trichilemmal cyst Squamous cell carcinoma
Proliferating trichilemmal cyst Melanoma
Seborrheic keratosis Proliferating trichilemmal cyst
Lipoma Angiosarcoma
Dermoid cyst Cutaneous lymphoma
Pilomatricoma Cutaneous metastases
Steatocystoma multiplex
Actinic keratosis
Nevus sebaceous
Melanocytic nevus
Cylindroma
Angiolymphoid hyperplasia with eosinophilia
Neurothekeoma
Infantile myofibromatosis
Hemangioma
Table 1. The neoplasms of the scalp.
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It affects 5–10% of the population with a female preponderance [77, 80]. TC may be sporadic 
or they may be inherited as an autosomal dominant trait. It presents as an asymptomatic or 
mildly painful firm nodule but frequently they are multiple. The cysts are classically located 
in areas bearing hair follicle, mostly on the scalp and rarely the face, trunk and extremities 
may be involved. They are usually 1–2 cm in size but can be much larger.
Histopathologic evaluation can confirm the diagnosis. Histopathologically TCs are lined 
by stratified squamous epithelial cells and consist homogenous eosinophilic material that 
frequently show foci of calcification and abrupt keratinisation without an intervening 
granular layer.
TC may be misdiagnosed as epidermal cyst clinically but unlike epidermal cyst, no punctum 
is seen. Treatment is by complete excision. Trichilemmal cysts typically can be extracted more 
easily than epidermoid cysts [77, 79, 80].
6.2. Proliferating trichilemmal cyst
Proliferating trichilemmal cyst [PTC] also known as proliferating pilar tumour is a rare neo-
plasm arising from the isthmus region of the outer root sheath of the hair follicle. It can be 
inherited in an autosomal dominant pattern. It occurs most commonly on the scalp in women 
older than 50 years. Most tumours arise within a pre-existing trichilemmal cyst but some 
PTCs arise de novo [81]. They have different clinical and histologic features from trichilem-
mal cyst. PCTs may slowly or rapidly grow into a large, solitary, well-circumscribed pain-
less mass overlying alopecia. The size may range from 1 to 10 cm, although there have been 
reports of lesions exceeding 25 cm in diameter. Inflammation, ulceration, bleeding and/or 
yellowish discharge may occur and may be clinically confused with squamous cell carcinoma. 
They usually behave in a benign nature but malignant transformation with local invasion and 
metastasis has also been described [82, 83].
Broad anastomosing bands and lobules of squamous epithelium in the cyst wall are the histo-
logic features of PCT. PTC shows features of typical trichilemmal cyst, but additionally shows 
extensive epithelial proliferation, variable cytologic atypia and mitotic activity. Complete 
excision is recommended for the treatment of PCT owing to their potential for locally aggres-
sive behaviour and malignant transformation [81, 83]. If malignant PTC with multi-nodal 
metastasis is identified, wide local excision with 1-cm margins should be performed, followed 
by adjuvant chemotherapy and radiation to prevent recurrence [84].
6.3. Nevus sebaceous
Nevus sebaceous [NS] is uncommon hamartomatous lesions that exhibits epidermal, follicular, 
sebaceous and apocrine malformation to varying degrees. It was first described by Jadassohn 
in 1895. It occurs most commonly on the head and neck while similar lesions elsewhere on the 
body are termed verrucous epidermal nevi. It often presents at birth with an incidence of 0.5–1% 
[85]. The characteristic clinical feature is a well-circumscribed, flesh-coloured, bald patch on the 
scalp at birth. At puberty, lesion grows proportionally with the patient and tends to be slightly 
yellow or orange, thick, velvety and verrucous surface. Familial cases have been reported [86].
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Development of benign or malignant adnexal neoplasms may occur in NS, usually in adult-
hood. Syringocystadenoma papilliferum and trichoblastoma are the most common benign 
tumours arising in NS [87]. Other benign tumours include trichilemmoma, sebaceous ade-
noma, apocrin adenoma and poroma. Malignant transformation can develop in 10–15% of 
lesions in some series and basal cell carcinoma is the most seen malignant tumour. Actually, 
this rate is less than 1% of cases. Development of six different tumours has also been reported 
in one solitary lesion [88].
Histologically, early lesions show few abnormal features. A few misshapen hair follicles and 
small apocrine glands may be identifiable during childhood. At adolescence, as the lesions 
clinically thicken, NS looks like an epidermal nevus, with papillated epidermal hyperplasia, 
abortive hair follicles and enlarged apocrine glands.
The lesions must be distinguished from aplasia cutis congenita, congenital nevi, epidermal 
nevus syndrome and seborrheic keratosis. Although there is no consensus regarding the NS, 
increasing to the possibility of malignant tumour outgrowth from a NS with age, it is nec-
essary to prophylactic excision especially in adulthood. Photodynamic therapy with topical 
aminolevulinic acid is another treatment option for non-surgical treatment [89].
6.4. Cylindroma
Cylindroma is a benign skin adnexal tumour differentiating towards either the eccrine or 
apocrine line. It has two different clinical presentations, solitary and multiple. Solitary cyl-
indroma is a slow growing, benign tumour effecting the scalp especially the capillitium and 
neck region. Solitary cylindromas affect middle-aged and elderly persons and female-to-male 
ratios are 6:1 and 9:1 [90].
Multiple cylindromas are very rare and inherited in an autosomal dominant pattern by muta-
tions in CYLD1, a tumour suppressor gene. They frequently occur on the scalp and rarely 
on the trunk. The term turban tumour is used to describe multiple cylindromas. Since the 
nodules enlarge and coalesce on the scalp, the patient looks as wearing a turban. Multiple cyl-
indromas should suggest of Brook-Spiegler syndrome, which has been characterised by the 
development of multiple skin appendage tumours, such as cylindromas, trichoepitheliomas 
and spiradenomas [91, 92].
Histopathology is diagnostic with islands of basaloid cells in a jigsaw puzzle-like pattern 
separated by hyaline basement membrane material that is PAS positive. Eosinophilic PAS-
positive hyaline material in globules is also seen within the lobules [93].
Differential diagnosis of cylindroma includes trichilemmal cysts, basal cell carcinoma, spirad-
enoma and dermatofibroma. Under dermatoscopy, cylindromas demonstrates arborising tel-
angiectasia and scattered white globules on a background of white to salmon-pink. Vascular 
branches can be seen at the periphery which may extend into the centre of the lesion [94].
For solitary lesions, the treatment option is complete excision. Other treatments include elec-
trodesiccation/curettage, cryotherapy and carbon dioxide laser. The patients with multiple 
cylindromas should follow up because of the tendency for new lesions to develop [95].
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